Celcuity (CELC) Capital Expenditures (2016 - 2025)
Celcuity (CELC) reported Capital Expenditures of $53000.0 for Q4 2025, up 17.78% on a YoY basis from $45000.0 in Q4 2024, and down 45.36% quarter-over-quarter from $97000.0 in Q3 2025.
Celcuity (CELC) Capital Expenditures (2016 - 2025) Analysis & Trends
Celcuity has reported Capital Expenditures for 10 years, with the latest figure at $53000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 17.78% year-over-year to $53000.0; the trailing twelve-month figure through Dec 2025 stood at $249000.0 (changed 0.4% YoY), and the FY2025 full-year result was $249000.0, changed 0.4% from the prior year.
- Capital Expenditures for Q4 2025 stood at $53000.0, down from $97000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $112044.0 in Q4 2022, with the low at $4854.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $41865.5 across 5 years, with a median of $35849.5 in 2023.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 78.88% — and 2024, when it soared 1218.5%.
- Celcuity's Capital Expenditures stood at $9939.0 in 2021, then soared by 1027.32% to $112044.0 in 2022, then tumbled by 70.82% to $32699.0 in 2023, then surged by 37.62% to $45000.0 in 2024, then rose by 17.78% to $53000.0 in 2025.
- The last three Capital Expenditures figures came in at $53000.0 (Q4 2025), $97000.0 (Q3 2025), and $39000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 32,699.00 |
| Dec 31, 2023 | 32,699.00 |
| Sep 30, 2023 | 53,104.00 |
| Sep 30, 2023 | 53,104.00 |